European Biopharmaceutical Enterprises (EBE) is the European trade association that represents biopharmaceutical companies of all sizes operating in Europe. It was established in 2000 as a specialised group of EFPIA and is headquartered in Brussels. Membership in EBE is open to all companies using biotechnology to discover, develop and bring new medicinal products to market.
EBE’s focus on the biopharmaceutical sector provides targeted and results-oriented support for its members. It has developed a wide range of activities and services for members, embracing policy advocacy, regulatory intelligence, strategic communications, business development, networking, education and training.
EBE coordinates specialised committees and task forces composed of member company representatives to provide industry input to the European legislative and regulatory process. Through EBE, policy makers can meet with the sector to understand the business implications of existing or proposed legislation regulating healthcare biotech product development and distribution. The number and complexity of regulations affecting the biopharmaceutical sector is also increasing and regulators need a forum for industry consultation.
EBE has also developed specific programmes to address technical matters (e.g. biotech manufacturing standards and good practices) and cover growing niche markets (e.g orphan medicinal products).